Pharmaceuticals plant to be built in Volgograd region for 3 bln rubles
VOLGOGRAD. Sept 3 (Interfax) - The Volgograd region will be the location of the pharmaceuticals enterprise as part of a federal program for import substitution, Russian Industry and Trade Minister Denis Manturov told journalists on Wednesday.
He participated in the brick-laying ceremony for the construction of the new plant, which is being carried out by FSUE Moscow Endocrine Plant.
The minister said that livestock products will be raw materials for the new factory. "Today livestock enterprises not only are recycling, they even pay money for recycling animal products. And here from the livestock products, substances are made with animal origin for the creation of prepared medicines," he said.
The regional government told Interfax that the total cost of the work amounts to more than 3 billion rubles. The enterprise will be built by 2018, it will produce 10 types of pharmaceutical substances for 20 medicines.
The regional authorities suggested several production sites for production of drugs from pharmaceutical substances to the management of FSUE Moscow Endocrine Plant. Territory in the city of Volzhsky was chosen. The new factory will be built "from scratch."
The Russian Industry and Trade Ministry took the initiative to limit state purchases of imported drugs. Manturov said that this initiative of the authorities is aimed at stimulating domestic pharmaceutical production in Russia and is not an answer to sanctions.
